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Fig 1. Observed survival.
Fig 2. Survival for propensity-matched cohorts.
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ruptured TAAA (P < .001).
Conclusions: A decline in the number of TAAA cases was observed
over the study period; however, the costs associated with treatment
increased signiﬁcantly. The overall in-hospital mortality is decreasing for
TAAAs. A sharp rise in the use of endovascular techniques for the manage-
ment of TAAA was seen over the study period. The overall mortality of
TEVAR was signiﬁcantly lower compared with OAR.
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Objectives: Clinically signiﬁcant steal syndrome (SS) occurs in a sub-
set of dialysis patients with arteriovenous (AV) access. Factors associated
with SS are poorly understood. Severe symptoms require access revision
or sacriﬁce, potentially jeopardizing access options. Our objective was to re-
view our dialysis access experience to identify factors associated with SS.
Methods: We reviewed all adult patients undergoing their ﬁrst upper
extremity access, AV ﬁstula (AVF) or AV graft (AVG), between January
2008 and July 2011 at a single center. Medical, demographic, and access
characteristics were collected from our electronic medical record and a local
dialysis center’s database. Patients who required correction of SS were
compared with the larger access cohort. Statistical analysis included the
Fisher exact test and c2 for noncontinuous variables and the unpaired t-
test for continuous variables.
Results: Of 303 patients, 15 required correction for SS (eight of 232
AVF and seven of 71 AVG). Eight were ligated; two were initially banded,
then ligated; and ﬁve underwent distal revascularization with interval ligation.
Coronary artery disease was more prevalent in SS patients (66.7% vs 25%; P ¼
.001); the same was found with peripheral arterial disease (40% vs 13.8%; P ¼
.02). Further, more patients with SS were on Plavix for cardiovascular reasons
(40% vs 9%;P¼ .002). SS only developedwithAVF/AVGusing brachial artery
inﬂow. No cases of SS arose from radial/ulnar inﬂow (P¼ .03). All AVGs with
SS had a straight conﬁguration; no looped AVG developed steal (P ¼ .02).
Other patient characteristics such as age, sex, race, hypertension, diabetes mel-
litus, congestive heart failure, cerebrovascular accident, cause of end-stage renal
disease, and other medication history were not different between groups.
Conclusions: Clinically signiﬁcant SS is associated with disease in coro-
nary and peripheral arterial beds. In addition, the use of brachial artery inﬂow
and straight AVG conﬁguration are associated with SS. Patients with these
characteristics need additional vigilance for steal-associated symptoms.
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Descending Thoracic Aortic Surgery Is Common After Type A Aortic
Dissection Repair: Perspectives From Thomson Reuters MarketScan
Database
Ross Milner, MD, Sandra Ham Michael Hur. Surgery, University of
Chicago, Chicago, Ill
Objectives: The current standard of surgical repair for type A aortic
dissection (TAAD) does not guarantee freedom from subsequent aortic op-
erations; therefore, consideration of simultaneous treatment beyond the
ascending aorta is warranted. This study was conducted to report the na-
tional rates and the timing of proximal and distal reoperations after operative
repair of TAAD based on available patient-level admissions data.
Methods: Admissions data for patients with TAAD were identiﬁed
and obtained from Thomson Reuters MarketScan Database using Interna-
tional Classiﬁcation of Diseases, 9th Revision, Clinical Modiﬁcation codes.
From 2003 to 2011, patients aged >18 years with thoracic or thoracoabdo-
minal diagnoses who underwent surgical repair or aortic resection, or both,
were identiﬁed. From this population, 2041 patients with $12 months of
follow-up data who were discharged alive after index admissions for
TAAD were described. Primary outcome measures were rates of reoperation
for any aortic location. Patient demographics, comorbidities at admission,
and interval to reoperation were also obtained from the database.
Results: A total of 3463 patients with TAAD who underwent
repair were identiﬁed. The mortality rate was 7.8% for the initial
repair. Of 3018 patients who were available for follow-up, 2041 pa-
tients had >1 year of follow-up. The mean age was 58.0 6 13.2years, and 70% were male. Eighty-seven patients (4.26%) required
95 reoperations (33.1% of reoperations) for the ascending aorta,
and 162 (7.94%) patients required 192 (66.9%) reoperations for the
descending thoracic aorta. The mean intervals were 436.7 6 593.9
days for ascending aortic surgery and 324.0 6 431.2 days for the
descending thoracic aorta after the initial admission for TAAD surgi-
cal procedures.
Conclusions: TAAD is a highly morbid and mortal diagnosis. The
initial surgery is high-risk, but our data demonstrate that future surgery is
common. In fact, the majority of the repeat surgical procedures are for
descending thoracic aortic complications. We believe that more aggressive
aortic stabilization may be warranted.
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Fig 1. 30-day freedom from major amputations after infrainguinal endo-
vascular interventions with and without IVUS.
JOURNAL OF VASCULAR SURGERY
1112 Abstracts October 2014Objectives: Advancements in endovascular therapy have made the
minimally invasive repair of juxtarenal and thoracoabdominal aneurysms a
possibility. Comparison of long-term results of endovascular repair (ER)
vs open repair (OR) of thoracoabdominal aneurysms is required to deter-
mine the most appropriate treatment options.
Methods: The Inpatient Medicare database from 2004 to 2011 was
investigated using International Classiﬁcation of Diseases, 9th Revision pro-
cedure codes for repair of abdominal, thoracic, and thoracoabdominal aortic
aneurysms with associated concomitant renal or mesenteric revasculariza-
tion for OR and ER. Fenestrated endovascular grafting codes were used
once available in 2011. Demographics, preoperative comorbidities, mortal-
ities, and postoperative complications were analyzed using the t-test for
continuous and the c2 test for categoric variables. Kaplan-Meier curves
and multivariable Cox models were used to estimate effect of treatment
on survival.
Results: A total of 4749 patients met inclusion criterion: 3757 OR
and 992 ER groups. The 30-day mortality was signiﬁcantly less after ER
(mean mortality: 12.3 for OR vs 8.2 for ER; P < .001). Patients after
OR had higher rates of renal failure (15.3% vs 9.4%) and cardiac (4.5%
vs 2.3%) and pulmonary insufﬁciency (11.5% vs3.6%). ER patients had
higher rates of peripheral vascular (1.8% vs 1%) and device malfunction
(6.9% vs 1.1%) complications. Although survival up to almost 2 years was
better after ER, survival curves converged after 21 months of follow-up
(Fig 1). Propensity-matched patients conﬁrmed a 2-year advantage for
ER over OR (Fig 2).
Conclusions: Like ER of abdominal aortic aneurysm, ER of thora-
coabdominal and juxtarenal aneurysms has a distinct 2-year advantage
but then becomes not statistically different at up to 7 years of follow-
up. This may reﬂect the prevalence of other comorbidities resulting in
late mortality in both groups. This preliminary study based on national re-
sults does support more in-depth long-term prospective analysis, especially
as techniques for thoracoabdominal repair become more standardized and
widespread.
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The Impact of Intravascular Ultrasound Utilization on Infrainguinal
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Objectives: Angiography alone may underestimate lower extremity
(LE) arterial disease burden. Intravascular ultrasound (IVUS) as an adjunc-
tive tool has been theorized to improve patency and lessen secondary pro-
cedures. We identiﬁed IVUS use for LE endovascular procedures to assess
outcomes.
Methods: Medicare beneﬁciaries undergoing infrainguinal endovas-
cular interventions with IVUS were identiﬁed from 2005 to 2009 MedPAR
and Carrier ﬁles using Current Procedural Terminology codes. Patients
were matched 1:2 to patients not receiving IVUS by a propensity score
based on age, gender, race, and comorbidities. The c2 test, Wilcoxon
rank sum test, Kaplan-Meier survival analysis, and Cox proportional hazards
modeling were used.
Results: A total of 1362 patients undergoing LE intervention with
IVUS were matched to 2724 patients not receiving IVUS. Mean age was
75 years, 52.6% were men, and 79.1% were white. The most common
indications were claudication (29.6%) and ulceration/gangrene (25.9%).
No differences in complications for IVUS vs non-IVUS, respectively,
were identiﬁed: cardiac (2.3% vs 2.4%; P ¼ .9), renal (6.8% vs 7.9%; P
¼ .2), bleeding (8.3% vs 8.2%; P ¼ .9), and embolism or thrombosis
(6.4% vs 7.9%; P ¼ .08). Total charges ($73,516 vs $69,221; P ¼
.046) and supply costs ($23,644 vs $15,322; P < .0001) were signiﬁ-
cantly higher with IVUS. The 30-day above-knee (1.8% vs 1.4%; P ¼
.4) and below-knee (3.2% vs 3.1%; P ¼ .9) amputation rates did not
differ between IVUS and non-IVUS, respectively (Fig 1). The 30-day
rates of repeat angioplasty (9.6% vs 8.7; P ¼ .3) and embolectomy
(1.3% vs 1.6%; P ¼ .4) did not differ, whereas rates of stenting (7.5%
vs 5.5%; P ¼ .01) and thrombolysis (3.4% vs 1.3%; P < .0001) were
higher for IVUS. Modeling demonstrated that IVUS use was not associ-
ated with reduced amputation rates (hazard ratio [HR], 1.03; 95% con-
ﬁdence interval [CI], 0.76-1.4), whereas black race (HR, 1.58; 95% CI,
1.12-2.23), renal failure (HR, 1.82; 95% CI, 1.30-2.56), and disease
severity were associated with amputation.
Conclusions: As an adjunctive tool during infrainguinal interven-
tions, IVUS was not associated with improved 30-day major amputa-
tion but was more frequently associated with thrombolysis andstenting. Total charges and supply costs were signiﬁcantly greater
with IVUS, suggesting that IVUS does not improve outcomes while
increasing hospital utilization.Author Disclosures: T. R. Vogel: None; V. Y. Dombrovskiy: None;
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Objectives: This study assessed aortic arch morphology and aortic
length in patients with dissection, traumatic injury, and aneurysm undergo-
ing thoracic endovascular aortic repair and identiﬁed characteristics speciﬁc
to the different pathologies.
Methods: We retrospectively evaluated the aortic arch
morphology and aortic length of 210 patients (49 dissection, 99 trau-
matic injury, 62 aneurysm) enrolled in three trials who received the
conformable Gore TAG thoracic endoprosthesis. The mean age was
43 6 19.6 years for trauma patients, 57 6 11.7 years for dissection
patients, and 72 6 9.6 years for aneurysm patients. A standardized
protocol was used to measure aortic arch diameter, length, and take-
off angle, and clock-face orientation of branch vessels. Differences in
arch anatomy and length were assessed using analysis of variance and
independent t-tests.
Results: Of the 210 arches evaluated, 22% had arch vessel com-
mon trunk conﬁgurations. The Table contains highlights of compre-
hensive measurements. The aortic diameter and the distance from
the left main coronary to the left common carotid were greater in
dissection patients than in trauma or aneurysm patients (P < .05).
The distances from the branch vessels to the celiac artery were greater
in dissection and aneurysm patients than in trauma patients (P < .05).
Aortic diameter was greater in aneurysm patients compared with
trauma patients (P < .05). The take-off angle of the innominate,
left common carotid, and left subclavian were greater, between 19%
and 36%, in trauma patients than in dissection and aneurysm patients
(P < .05). Clock-face orientation of the arch vessels varied between
pathologies.
Conclusions: Arch anatomy has signiﬁcant morphologic differ-
ences when comparing aortic pathologies. Describing these differences
in a large sample of patients is beneﬁcial for device designs and pa-
tient selection that plays a critical role in outcomes.
